Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

135.11
Delayed Data
As of Feb 16
 +1.76 / +1.32%
Today’s Change
13.09
Today|||52-Week Range
154.75
+47.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-90.2M-86.2M-68.7M-26.4M
 
 
 
 
 
Depreciation516.0K673.0K662.0K156.00
 
 
 
 
 
Total Other Cash Flow6.0M7.4M4.3M9.9M
 
 
 
 
 
Funds From Operations-83.6M-78.1M-63.7M-16.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-6.2M868.0K7.7M1.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-77.4M-78.9M-71.4M-17.6M
 
 
 
 
 
 
InvestingIncrease In Investments-114.2M-93.8M-117.1M-10.7M
 
 
 
 
 
Decrease In Investments90.3M85.2M137.2M26.1M
 
 
 
 
 
Capital Expenditures-769.0K-144.0K-58.0K-3.1K
 
 
 
 
 
Fixed Asset Disposal------697.5K
 
 
Other Investing - Sources0.000.000.005.8M
 
 
Net Cash Flow Investing-24.7M-8.8M20.0M22.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00--8.5M
 
 
Long Term Borrowings13.5M0.000.000.00
 
 
Long Term Debt Reduction-2.6M-9.5M-9.3M0.00
 
 
 
 
Net Proceeds Stock Sale58.2M94.8M49.6M6.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing69.0M85.3M40.4M14.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash-33.0M-2.5M-11.1M18.8M